KDEV.ST

Karolinska Development AB (publ) [KDEV.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

KDEV.ST Stock Summary

In the News

KDEV.ST Financial details

Company Rating
Sell
Market Cap
415.35M
Income
-37.81M
Revenue
1.85M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
8
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
7.78
Forward P/E
-
PEG
-1.03
P/S
235.23
P/B
0.39
P/C
-
P/FCF
-18.61
Quick Ratio
16.63
Current Ratio
17.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-103.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-69.74%
Revenue last 5Y
-3.67%
Revenue Q/Q
-9.47%
EPS Q/Q
-115.51%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
5%
ROE
5%
ROC
0.04%
Gross Margin
100%
Oper. Margin
2679%
Profit Margin
3051%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.41-1.948
52W High
+51.8%
52W Low
+51.8%
RSI
46
Rel Volume
0.39
Avg Volume
141.17K
Volume
54.77K
Perf Week
-3.92%
Perf Month
-6.3%
Perf Quarter
3.27%
Perf Half Y
-2.06%
-
-
-
-
Beta
0.383
-
-
Volatility
0.02%, 0.03%
Prev Close
-0.13%
Price
1.518
Change
-0.13%

Something similar

Top by Market Cap
M&M.NS
ABEC.DE
GOOG
BRK-B
MIX.JO
Same Sector
THTX
GOSS
SRDX
605266.SS
6669.HK
Same Price Range
6811.HK
002506.SZ
3833.HK
G13.SI
TCBP
Similar Market Cap
YMAB
XUCM.L
SOI
UMI
1966.HK

Company Profile

Healthcare Biotechnology

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.